Macleods Pharmaceuticals Limited Unclassified
FDA Approved Drugs
Macleods Pharmaceuticals Limited Unclassified
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 36
- Latest Approval Date -
- Data Source FDA
- First Approval Date -
Company Overview
Company
Macleods Pharmaceuticals Limited Unclassified
Country
India
Website
Social Profiles
Company Snapshot
Macleods Pharmaceuticals Limited Unclassified
Atlanta Arcade, Marol Church Road, Andheri (East), Mumbai - 400059
India
www.macleodspharma.com/ exports@macleodspharma.com View on MapFDA Approved Drug Records ( 36 records )
Drug Name
ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
-
Active Ingredient
ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE
Application Number
217830
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
-
Active Ingredient
ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE
Application Number
217830
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
1000MG
Approval Date
-
Active Ingredient
METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN
Application Number
215255
Product Number
1
Dosage Form
-
Strength
1000MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN
Application Number
215255
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
150MG
Approval Date
-
Active Ingredient
METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN
Application Number
215255
Product Number
3
Dosage Form
-
Strength
150MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
500MG
Approval Date
-
Active Ingredient
METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN
Application Number
215255
Product Number
4
Dosage Form
-
Strength
500MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CRISABOROLE
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
-
Active Ingredient
CRISABOROLE
Application Number
216242
Product Number
1
Dosage Form
-
Strength
2%
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DOLUTEGRAVIR SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
-
Active Ingredient
DOLUTEGRAVIR SODIUM
Application Number
214397
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DOLUTEGRAVIR SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
-
Active Ingredient
DOLUTEGRAVIR SODIUM
Application Number
214397
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DOLUTEGRAVIR SODIUM
Product Number
3
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
-
Active Ingredient
DOLUTEGRAVIR SODIUM
Application Number
214397
Product Number
3
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DOLUTEGRAVIR SODIUM
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
-
Active Ingredient
DOLUTEGRAVIR SODIUM
Application Number
214566
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Product Number
1
Dosage Form
-
Strength
50MG/300MG/300MG
Approval Date
-
Active Ingredient
DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
Application Number
210796
Product Number
1
Dosage Form
-
Strength
50MG/300MG/300MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Product Number
1
Dosage Form
-
Strength
600MG;300MG;300MG
Approval Date
-
Active Ingredient
EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
Application Number
205861
Product Number
1
Dosage Form
-
Strength
600MG;300MG;300MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG;500MG
Approval Date
-
Active Ingredient
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
Application Number
212373
Product Number
1
Dosage Form
-
Strength
5MG;500MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
5MG;1000MG
Approval Date
-
Active Ingredient
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
Application Number
212373
Product Number
2
Dosage Form
-
Strength
5MG;1000MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
12.5MG;500MG
Approval Date
-
Active Ingredient
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
Application Number
212373
Product Number
3
Dosage Form
-
Strength
12.5MG;500MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
12.5MG;1000MG
Approval Date
-
Active Ingredient
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
Application Number
212373
Product Number
4
Dosage Form
-
Strength
12.5MG;1000MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
IRBESARTAN; HYDROCHLOROTHIAZIDE
Product Number
3
Dosage Form
-
Strength
300MG; 25MG
Approval Date
-
Active Ingredient
IRBESARTAN: HYDROCHLOROTHIAZIDE
Application Number
202414
Product Number
3
Dosage Form
-
Strength
300MG; 25MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE AND STAVUDINE
Product Number
1
Dosage Form
-
Strength
150MG; 30MG
Approval Date
-
Active Ingredient
LAMIVUDINE; STAVUDINE
Application Number
22541
Product Number
1
Dosage Form
-
Strength
150MG; 30MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
Product Number
1
Dosage Form
-
Strength
150MG;200MG;30MG
Approval Date
-
Active Ingredient
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
Application Number
22537
Product Number
1
Dosage Form
-
Strength
150MG;200MG;30MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
Product Number
1
Dosage Form
-
Strength
150MG; 200MG; 300MG
Approval Date
-
Active Ingredient
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
Application Number
202589
Product Number
1
Dosage Form
-
Strength
150MG; 200MG; 300MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Product Number
1
Dosage Form
-
Strength
300MG; 300MG
Approval Date
-
Active Ingredient
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Application Number
203283
Product Number
1
Dosage Form
-
Strength
300MG; 300MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
METFORMIN HYDROCHLORIDE || SITAGLIPTIN
Application Number
212338
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
-
Active Ingredient
METFORMIN HYDROCHLORIDE || SITAGLIPTIN
Application Number
212338
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE
Product Number
3
Dosage Form
-
Strength
1000MG
Approval Date
-
Active Ingredient
METFORMIN HYDROCHLORIDE || SITAGLIPTIN
Application Number
212338
Product Number
3
Dosage Form
-
Strength
1000MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
MILNACIPRAN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
-
Active Ingredient
MILNACIPRAN HYDROCHLORIDE
Application Number
210944
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
MILNACIPRAN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
-
Active Ingredient
MILNACIPRAN HYDROCHLORIDE
Application Number
210944
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
MILNACIPRAN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
MILNACIPRAN HYDROCHLORIDE
Application Number
210944
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
MILNACIPRAN HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
-
Active Ingredient
MILNACIPRAN HYDROCHLORIDE
Application Number
210944
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SITAGLIPTIN PHOSPHATE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
-
Active Ingredient
SITAGLIPTIN PHOSPHATE
Application Number
211073
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SITAGLIPTIN PHOSPHATE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
SITAGLIPTIN PHOSPHATE
Application Number
211073
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SITAGLIPTIN PHOSPHATE
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
-
Active Ingredient
SITAGLIPTIN PHOSPHATE
Application Number
211073
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VORTIOXETINE HYDROBROMIDE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
-
Active Ingredient
VORTIOXETINE
Application Number
211165
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VORTIOXETINE HYDROBROMIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
-
Active Ingredient
VORTIOXETINE
Application Number
211165
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VORTIOXETINE HYDROBROMIDE
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
-
Active Ingredient
VORTIOXETINE
Application Number
211165
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VORTIOXETINE HYDROBROMIDE
Product Number
4
Dosage Form
-
Strength
5MG
Approval Date
-
Active Ingredient
VORTIOXETINE
Application Number
211165
Product Number
4
Dosage Form
-
Strength
5MG
Approval Date
-
Regulatory Status
Unclassified
Drug Status Breakdown
36 total- Unclassified
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE
Application Number
217830
Product Number
2
Active Ingredient
ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE
Dosage Form
-
Strength
5MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.